Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to determine if a single dose of LY2541546 has any side effects on the body and to determine how long and how much LY2541546 stays in the bloodstream of the body.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Additional Exclusion Criterion for Participants in Double Blind Groups Only
Additional Exclusion Criterion for Participants in Open Label Groups
Primary purpose
Allocation
Interventional model
Masking
60 participants in 9 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal